Vito J. Palombella, Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC. (INFI), sold 4,736 shares at $15.00 ($71K) on 2014-02-25, disclosed to the SEC on 2014-02-27.
Scheduled sale ($71k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INFI | SELL | 2015-06-16 | $52K | — | Filing → |
| INFI | SELL | 2014-12-16 | $77K | — | Filing → |
| INFI | SELL | 2014-11-28 | $71K | — | Filing → |